OTCs in Action Episode 59: Erasing painful memories in Russia

OTCinActionheader

“Our life is full of events, sometimes unintended and unpleasant. None of us are immune from falling, getting cut, being in an accident or having surgery. Fortunately, the modern level of medicine is that most of these situations are repairable. But the memory of the incident is likely to scar. Unfortunately, the scar does not always work carefully and quietly. If this happens to you, know that you are not alone. Pathological scars – a common problem. About 15% of people who have had any surgery or injury have unsightly scars. This means that over a million people are in need of treatment. Imoferaza cream will help you to adjust the appearance of the scar and make it inconspicuous.” (translated from Russian)

This week OTCs are in Action in Russia, where NPO Petrovax Pharm has launched Imoferaza to treat scarring with hyaluronidase enzyme technology. The product acts on the connective tissue that forms the basis of a scar. Applications described on the brand’s website include skin injuries, burns, tattoo removals, piercings, acne (post-acne) and make the preventive claim of “reduces the likelihood of unsightly scar”. The active ingredient is delivered in a cream formulation that soothes and softens skin while helping it retain moisture.

Although the technology is surely a benefit for Russian consumers, what caught OTCs in Action’s eye is the brand’s website graphics, which emphasise the emotional pain that can linger from scars:

imoferaza

 

For more information on Nicholas Hall’s OTC INSIGHT regional journals, click the link below:

http://www.insight.nicholashall.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s